Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study (Q46916625)
Jump to navigation
Jump to search
scientific article published on 27 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study |
scientific article published on 27 January 2006 |
Statements
1 reference
Combined PEG liposomal doxorubicin and gemcitabine are active and have acceptable toxicity in patients with platinum-refractory and -resistant ovarian cancer after previous platinum-taxane therapy: a phase II Austrian AGO study (English)
1 reference
E Petru
1 reference
L Angleitner-Boubenizek
1 reference
A Reinthaller
1 reference
M Deibl
1 reference
A G Zeimet
1 reference
B Volgger
1 reference
A Stempfl
1 reference
C Marth
1 reference
27 January 2006
1 reference
1 reference
102
1 reference
2
1 reference
226-229
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference